lobbying_activities: 1994925
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1994925 | b1f5e704-50cd-4740-901e-a3d798fb6de1 | Q2 | AVENUE SOLUTIONS | 72111 | JAZZ PHARMACEUTICALS, INC. | 2017 | second_quarter | PHA | S. 974, Creating and Restoring Equal Access to Equivalent Samples Act of 2017 (CREATES Act of 2017); H.R. 2051, FAST Generics Act | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2017-07-19T11:01:06.270000-04:00 |